81 related articles for article (PubMed ID: 2827024)
1. Cholecystokinin and glucagonoma.
Philippe J; Powers AC; Brand SJ
N Engl J Med; 1988 Jan; 318(2):121-2. PubMed ID: 2827024
[No Abstract] [Full Text] [Related]
2. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
[TBL] [Abstract][Full Text] [Related]
3. Ghrelin expression in islet cell tumors: augmented expression of ghrelin in a case of glucagonoma with multiple endocrine neoplasm type I.
Iwakura H; Hosoda K; Doi R; Komoto I; Nishimura H; Son C; Fujikura J; Tomita T; Takaya K; Ogawa Y; Hayashi T; Inoue G; Akamizu T; Hosoda H; Kojima M; Kangawa K; Imamura M; Nakao K
J Clin Endocrinol Metab; 2002 Nov; 87(11):4885-8. PubMed ID: 12414844
[TBL] [Abstract][Full Text] [Related]
4. [An autopsy case of glucagonoma associated with production of several hormones].
Fujise K; Matsuura T; Nakagawa J; Egawa K; Hihara M; Nakahara M; Kawase H; Kitahara T; Ohara K; Joh K
Nihon Naika Gakkai Zasshi; 1988 Jun; 77(6):880-1. PubMed ID: 2906354
[No Abstract] [Full Text] [Related]
5. [A glucagon-secreting alpha-cell carcinoma of the pancreas].
Matsumoto J; Noto N; Kikuchi Y; Kitazima S; Kaimori M; Sasaki G; Ohto T; Nakamura K
Nihon Shokakibyo Gakkai Zasshi; 1985 Feb; 82(2):330-4. PubMed ID: 2987580
[No Abstract] [Full Text] [Related]
6. [Malignant pancreatic glucagonoma treated by total radical pancreatectomy. 1st Spanish case report and review of the world literature].
Martínez Díez M; Castiella Muruzábal T; Aguilella Diago V; Ingelmo Setien A; García Gil A; Garín Chesa P; González González M
Rev Esp Enferm Apar Dig; 1983 May; 63(5):401-20. PubMed ID: 6308726
[No Abstract] [Full Text] [Related]
7. [Glucagonoma].
Shima K; Tsujii T; Sasano N; Doi O; Kyoba S
Gan No Rinsho; 1970 Aug; 16(8):866-70. PubMed ID: 4318397
[No Abstract] [Full Text] [Related]
8. Lack of p53 immunoreactivity in pancreatic endocrine tumors.
Lee CS
Pathology; 1996 May; 28(2):139-41. PubMed ID: 8743819
[TBL] [Abstract][Full Text] [Related]
9. A combined glucagonoma and VIPoma syndrome. First pathologic and clinical report.
Cavallo-Perin P; De Paoli M; Guiso G; Sapino A; Papotti M; Coda R; Pagano G
Cancer; 1988 Dec; 62(12):2576-9. PubMed ID: 2847862
[TBL] [Abstract][Full Text] [Related]
10. Degradation during storage of high molecular weight immunoreactive insulin (HWIRI) and proinsulin (PLC) in extracts of Benign insulinomas and adjacent pancreatic tissue.
Villaume C; Beck B; Pointel JP; Drouin P; Debry G
Horm Metab Res; 1981 Sep; 13(9):528-9. PubMed ID: 6271661
[No Abstract] [Full Text] [Related]
11. [Glucagonomas. Clinical, biological, anatomopathological and therapeutic aspects (general review of 130 cases].
Guillausseau PJ; Guillausseau C; Villet R; Kaloustian E; Valleur P; Hautefeuille P; Lubetzki J
Gastroenterol Clin Biol; 1982 Dec; 6(12):1029-41. PubMed ID: 6131007
[No Abstract] [Full Text] [Related]
12. Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development.
Lu J; Herrera PL; Carreira C; Bonnavion R; Seigne C; Calender A; Bertolino P; Zhang CX
Gastroenterology; 2010 May; 138(5):1954-65. PubMed ID: 20138042
[TBL] [Abstract][Full Text] [Related]
13. Increased amino acid clearance and urea synthesis in a patient with glucagonoma.
Almdal TP; Heindorff H; Bardram L; Vilstrup H
Gut; 1990 Aug; 31(8):946-8. PubMed ID: 2167278
[TBL] [Abstract][Full Text] [Related]
14. Characterization of immunoreactive forms of pancreatic polypeptide in islet cell tumors using antisera with different regional specificities.
O'Hare MM; Huda I; Sloan JM; Kennedy TL; Buchanan KD
Cancer; 1985 May; 55(9):1895-8. PubMed ID: 2983868
[TBL] [Abstract][Full Text] [Related]
15. GPR40 gene expression in human pancreas and insulinoma.
Tomita T; Masuzaki H; Noguchi M; Iwakura H; Fujikura J; Tanaka T; Ebihara K; Kawamura J; Komoto I; Kawaguchi Y; Fujimoto K; Doi R; Shimada Y; Hosoda K; Imamura M; Nakao K
Biochem Biophys Res Commun; 2005 Dec; 338(4):1788-90. PubMed ID: 16289108
[TBL] [Abstract][Full Text] [Related]
16. Islet cell tumors of the pancreas: clinico-biochemical correlations.
Khandekar JD
Ann Clin Lab Sci; 1979; 9(3):212-8. PubMed ID: 223492
[TBL] [Abstract][Full Text] [Related]
17. Biochemical composition of edge and center of malignant hamster insulinoma.
Feldman JM
Arch Pathol Lab Med; 1984 Nov; 108(11):909-11. PubMed ID: 6091591
[TBL] [Abstract][Full Text] [Related]
18. Endocrine pancreatic carcinoma.
Rothmund M; Stinner B; Arnold R
Eur J Surg Oncol; 1991 Apr; 17(2):191-9. PubMed ID: 1849844
[TBL] [Abstract][Full Text] [Related]
19. Impaired uptake of D-glucose by tumoral insulin-producing cells.
Sener A; Giroix MH; Malaisse WJ
Biochem Int; 1986 Jun; 12(6):913-9. PubMed ID: 3017352
[TBL] [Abstract][Full Text] [Related]
20. Expression, intracellular localization, and gene transcription regulation of the secretory protein 7B2 in endocrine pancreatic cell lines and human insulinomas.
Gherzi R; Fehmann HC; Eissele R; Göke B
Exp Cell Res; 1994 Jul; 213(1):20-7. PubMed ID: 7517367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
